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Abstract
Coronary angiography allows a direct evaluation of coronary anatomy. The aim of the present investigation was to search
for correlations between the magnitude of coronary artery disease, as assessed by angiography, and a number of systemic
parameters. A group of 116 patients (80 male, 36 female) with coronary heart disease diagnosed by angiography, aged
62.0610.5 years, was the subject of an observational study. Correlation and linear regression analysis using coronary artery
disease burden (CADB - sum of the percentage of the luminal stenosis encountered in all the lesions of the coronary arterial
trees) as dependent variable, and age, sex, plasma calcium, phosphorus, magnesium, glucose, HDL cholesterol, LDL
cholesterol, triglycerides, uric acid, estimated glomerular filtration rate and body mass index as independent variables, were
carried out. Significant correlation values versus CADB were seen with age (r 0.19, p 0.04), uric acid (r 0.18, p 0.048) and
fasting plasma glucose (r 0.33, p,0.001). Linear regression analysis, yielding a global significance level of 0.002, showed a
significant value for glucose (p 0.018) and for sex (0.008). In conclusion, among several systemic parameters studied, plasma
glucose was found to be correlated to coronary artery atherosclerosis lesions.
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Introduction
Coronary artery disease is a frequent and important disease, for
which a number of risk factors have been identified. Coronary
angiography allows a direct evaluation of coronary anatomy. The
study of the magnitude of coronary artery disease in patients with
confirmed disease may be of help in elucidating mechanisms
underlying growth of coronary atherosclerosis lesions. This type of
evidence may be of use, to be added to evidence on the risk of
having the disease, notwithstanding the fact that some of the
factors that increase risk may also increase growth.
Risk factors for ischemic heart disease include age, male sex,
high plasma cholesterol, high plasma glucose and excessive weight
[1]. More recently, a decrease in renal function was also noted to
be associated to coronary artery disease [2].
An estimate of coronary artery disease burden (CADB) can be
obtained by adding the degree of stenosis measured in every lesion
found atangiography [2],and thiswasthe method used in the present
investigation. In a cohort previously studied, including 110 patients
with acute coronary syndrome, relatively weak but significant
correlations were seen between CADB and decreased renal function,
on the one hand, and plasma calcium, on the other hand [2].
Atherosclerotic lesions frequently have not only lipid deposits, but
also calcium deposits inside the arterial wall. There is evidence that
a significant degree of similitude may exist between vascular
calcification mechanisms and bone metabolism [3–5]. The relation
between high plasma glucose and heart disease is also well
established [6]. Diabetes mellitus, a state of chronic hyperglycemia,
is frequently associated, not only to atherosclerosis, but also to other
types of vascular calcification such as medial calcification, the same
happening in patients with chronic renal failure [3]. Plasma glucose
is known to be associated to the severity of coronary artery disease
[7,8]. Magnesium is an element that plays a role in multiple
metabolic processes in physiology. Controversy exists, however, on
the association between magnesium metabolism and cardiovascular
disease,with differentsets ofdata pointing indifferentdirections [9].
Excessive weight/obesity is also currently seen as a risk factor for
cardiovascular disease, and it could, at least in some cases, act as a
cause for metabolic disturbances such as hyperglycemia [10]. Uric
acid is another parameter that is currently receiving attention in the
context of cardiac disease [11].
A number of biochemical parameters, including lipid fractions,
may be changed in the context of acute coronary syndrome, and
therefore it may be of interest to study outpatients, rather than
inpatients with acute coronary syndrome, when performing a
more comprehensive study including lipid fractions. The aim of
the present investigation was, once again, to search for correlations
between the magnitude of coronary artery disease, as assessed by
angiography, and a number of systemic parameters: age, plasma
calcium, phosphorus, magnesium, glucose, high density cholesterol
(HDL), low density cholesterol (LDL), triglycerides, uric acid,
estimated glomerular filtration rate and body mass index.
A possible interaction between lipid metabolism, calcium/
phosphorus metabolism, magnesium, fasting plasma glucose, uric
acid, renal dysfunction and excessive weight, on the one hand, and
the magnitude of coronary artery lesions, and therefore mecha-
nisms underlying lesion growth, on the other hand, was sought.
Methods
A cohort of 116 patients (80 male, 36 female) with coronary
heart disease diagnosed by angiography, aged 62.0610.5 years,
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patients were Caucasian and one was Asiatic. Patients were
observed at an outpatient Cardiology clinic.
The study had an observational character, since biochemical
studies were carried out after initial clinical evaluation (either
before or after angiographic study), at a time when patients were
under medical therapy that was not prescribed by any person
involved in the present study. The research protocol (including the
informed consent forms) was evaluated and approved by an
independent ethics committee (Comissa ˜o de E ´tica do Centro de
Sau ´de Sa ˜o Joa ˜o, Porto, Portugal). Patients were included if
coronary artery disease was confirmed by angiography, performed
after myocardial infarction or in the course of the study of angina
pectoris. Exclusion criteria included serious systemic diseases, such
as cancer and systemic infections.
Patients were evaluated under a protocol which included
electrocardiogram, echocardiogram, and plasma measurement of
total cholesterol, HDL (high density lipoprotein) cholesterol,
triglycerides, creatinine, calcium, phosphorus, magnesium and
uric acid (this latter parameter was not included in the initial
analysis but was added at a later stage). LDL (low density
lipoprotein) cholesterol values were calculated by the formula
LDL=total cholesterol – HDL cholesterol – (0.26triglycerides)
[12]. Biochemical measurements (as well as the other tests) were
performed under routine conditions, immediately after collection
of blood and in a completely blind way in what concerns the
present study. Additional diagnostic tests were performed
according to each case. One biochemical set of data was taken
for study in each patient, corresponding to the initial evaluation of
the patient. Body mass index (BMI) was calculated by use of the
formula weight (Kg)/height (m)
2.
Quantitative evaluation of coronary arteriography was per-
formed in all patients in two orthogonal views, either in the
context of acute coronary syndrome or study of angina pectoris.
The percent stenosis were calculated as the mean of the values
obtained in the two views. Coronary artery disease burden
(CADB) was estimated as the sum of the percentage of the luminal
stenosis encountered in all the lesions of the coronary arterial trees,
as previously reported [2].
Estimated Glomerular filtration rate (eGFR; milliliters per
minute per 1.73 m
2) was calculated according to the abbreviated
Modification of Diet in Renal Disease (MDRD) study equation:
GFR=1866(serum creatinine)
21.1546(age)
20.20360.742 (in wom-
en), as described in the corresponding K/DOQI Clinical Practice
Guidelines [13–15].
As the patients were studied as outpatients, angiography and
clinical/biochemical evaluation were not performed at the same
moment in time. The average number of months between
angiography and biochemical evaluation was 8.668.2, corre-
sponding to the fact that a number of patients underwent coronary
artery bypass surgery during that time interval.
Plasma samples were taken from patients either under lipid-
lowering drug therapy (98 samples) or not under such therapy (18
samples). Statins (3-hydroxy-3-methyl-glutaryl coenzyme A reduc-
tase inhibitors) were used in 96 cases treated for dyslipidemia, in
some cases in association to other types of drugs, whereas a fibrate
was used as the sole lipid-lowering drug in two patients.
Antidiabetic drugs were used in 28 patients, including insulin in
nine patients and several types of oral drugs in the remaining
cases. Data were missing for BMI in 3 patients.
Taking into consideration a possible interaction between glucose
metabolic pathways and magnesium, possiblyat the insulinreceptor
level, a composite parameter glucose/magnesium product was
constructed by multiplying the values for each parameter.
Statistical analysis
Data are presented as arithmetic mean and standard deviation.
Correlations between the various parameters under study were
calculated by using the Spearman correlation coefficient. Multiple
linear regression, taking as dependent variable the estimation of
CADB and as independent variables sex, age, plasma calcium,
phosphorus, magnesium, glucose, HDL, LDL, triglycerides, uric
acid, estimated glomerular filtration rate and body mass index,
was performed, with the calculation of the overall probability and
subsequent calculation of the individual probabilities for each
independent variable. In order to perform linear regression study,
all data was the subject of base 10 logarithmic transformation,
except for sex (which was entered as either 1 for male and 2 for
female patients). Pairs of means were compared by using the
Mann- Whitney U test. Probability values,0.05 were considered
significant. Statistical calculations were made by using the
Statistical Package for the Social Sciences software (version 16.0).
Results
Mean values for the different parameters under study are shown
in Table 1. Correlation (univariable) analysis showed a number of
significant correlations to exist. Significant correlation values
versus CADB were seen with age (r 0.19, p 0.04), uric acid (r 0.18,
p 0.048) and fasting plasma glucose (r 0.33, p,0.001).
Linear regression analysis (Table 2), yielding a global signifi-
cance level of 0.002, showed a significant value for glucose (p
0.018) and for sex (0.008).
The use of the composite parameter, glucose/magnesium
product, also yielded a significant correlation with CADB (r
0.37, p,0.001).
Subgroup analysis, by dividing patients by sex (male/female)
showed female patients to have lower mean values for CADB and
uric acid, and higher mean values for BMI, HDL cholesterol, LDL
cholesterol and plasma phosphorus (Table 3).
Table 1. Descriptive statistics for a number of parameters
measured in 116 patients with cardiovascular disease.
Mean STD N
Age 62.0 10.5 116
Ca 2.37 0.10 116
P 33.2 5.1 116
Mg 1.64 1.31 116
HDL 48.2 11.6 116
LDL 123.6 41.8 116
TG 157.7 95.2 116
Glucose 118.9 (6.60) 50.1 (2.78) 116
BMI 27.8 4.9 113
eGFR 77.3 15.6 116
Uric acid 56.9 15.8 116
Age presented in years. Ca- plasma calcium, mmol/l; P- plasma phosphorus,
mg/L; Mg- plasma magnesium, mEq/l; HDL- high density lipoprotein
cholesterol, mg/dl; LDL- low density lipoprotein cholesterol, mg/dl; TG-
triglycerides, mg/dl; Glucose- fasting plasma glucose, mg/dl (mmol/l); BMI-
body mass index (Kg/m
2); eGFR- estimated glomerular filtration rate, ml/min/
1.73 m
2; uric acid- plasma uric acid, mg/L; STD – Standard deviation; N- number.
doi:10.1371/journal.pone.0004322.t001
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Coronary artery atherosclerotic lesions frequently involve the
deposition of lipids and of calcium. Factors such as obesity,
diabetes mellitus and renal dysfunction may also play a role in
coronary atherosclerosis. In the present investigation, standard
coronary angiography was used as a means to estimate coronary
artery disease burden, by adding the values corresponding to each
lesion found [2]. Age, uric acid and fasting plasma glucose were
noted to be significantly correlated to CADB in univariate
analysis. Linear regression (multivariate) analysis, however, only
showed one of these parameters (fasting plasma glucose) to be
associated to CADB, the same happening with sex.
All patients under study in the present investigation had
coronary artery disease, and therefore no evaluation of the risk
of acquiring the disease was carried out, although some of the
parameters under study do act as risk factors. The present data
may be of relevance in what concerns mechanisms favouring the
growth of atherosclerosis lesions, since the parameter under
evaluation (CADB) aimed at assessing the magnitude of the total
burden of disease.
Lipids accumulate in arterial walls in atherosclerosis. In the present
study, we could find no evidence of an association between lipid
fractions and CADB. Most patients were treated with lipid-lowering
drugs, and this may be one of the reasons behind these negative
findings,particularly inwhat concernsLDLcholesterol. In the present
study, HDL cholesterol levels were also not correlated to CADB,
although previous studies have been shown HDL to be negatively
associated with the importance of coronary artery disease, whereas no
such relation was noted involving LDL cholesterol [16–17].
Calcium is yet another substance that is frequently found in
atherosclerotic lesions. In a previous study carried out in patients
with acute coronary syndrome [2], a relatively weak but significant
correlation was noted between plasma calcium and CADB. In the
present study, however, no significant correlation with CADB was
found either with calcium or phosphorus. The mean plasma
calcium measured in the present investigation (2.37 mmol/l,
n=116) was, in fact, significantly higher than in the previous study
(2.20 mmol/l, n=110), indicating that, as previously reported
[18], plasma calcium values measured in inpatients may be
different from values measured in outpatients, and may not hold
precisely the same physiological significance.
Renal dysfunction could act as a risk factor for coronary artery
disease [2]. However, it is unclear if renal dysfunction acts as a
cause for accelerated coronary artery disease or if it merely acts as
a surrogate marker for the overall systemic vascular system status
[2]. Obesity also acts as a risk factor for cardiovascular disease.
Previous studies have shown that increased BMI values may be
associated to lower coronary artery disease burden, a finding that
may depend on the fact that such patients are frequently studied at
an earlier age [19]. In the present investigation, no relation was
noted between BMI and CADB, neither in univariate nor in linear
regression analysis.
Diabetes mellitus is a well known risk factor for coronary artery
disease [6], as well as cardiovascular disease in general [20].
Glucose metabolism has been shown to correlate with the
angiographic importance of coronary artery disease, data in good
agreement with the present results [7–8]. Diabetes mellitus has
also been shown to be associated to coronary artery calcification in
asymptomatic subjects [21]. Elevated fasting plasma glucose in
type II diabetes mellitus is known to be frequently associated to
elevated plasma levels of plasma insulin. In the present results,
plasma glucose showed a significant relation versus CADB in both
univariate and multivariate analysis, indicating that glucose
metabolic pathways may play a role in the growth of atheroscle-
rotic lesions. This may happen not necessarily through the action
of elevated glucose levels, but perhaps through the action of
insulin. Insulin could act not only on insulin receptors but also on
Table 2. Linear regression analysis, taking CADB (after base
10 logarithmic transformation) as dependent parameter and
10 parameters as independent parameters, as measured in
116 patients with coronary artery disease.
Dependent
variable CADB
Standardized
Coefficients (Beta)
ANOVA p=0.002
(F 2.876)
p
HDL 20.14 0.21
LDL 0.08 0.48
TG 0.09 0.35
Ca 0.06 0.51
P 0.05 0.58
Mg 0.09 0.34
Gluc 0.25 0.018
Age 0.06 0.54
eGFR 20.16 0.14
BMI 20.05 0.63
Uric acid 0.01 0.95
Sex 20.31 0.008
HDL – HDL cholesterol; LDL – LDL cholesterol; TG – triglycerides; Ca – calcium; P
– phosphorus; Mg- magnesium; Gluc- fasting glucose; eGFR- estimated
glomerular filtration rate; BMI- body mass index; uric acid- plasma uric acid; p-
probability.
doi:10.1371/journal.pone.0004322.t002
Table 3. Subgroup analysis (male/female) - mean6standard
deviation.
Variable Male (n=80) Female (n=36) P
CADB 314.46169.4 206.46144.7 0.001
HDL 46.4610.6 52.3612.8 0.014
LDL 116.9635.8 138.5650.1 0.034
TG 159.86103.2 153.1675.4 0.67
Ca 2.3760.10 2.3660.10 0.92
P 32.1+4.9 35.7+4.6 ,0.001
Mg 1.6560.13 1.6160.13 0.21
Glucose 118.7644.3 119.3661.7 0.33
Age 62.5610.2 60.8611.2 0.49
eGFR 78.0615.6 75.6615.7 0.54
BMI 27.064.0 29.866.2 0.042
Uric acid 60.6615.5 48.7+13.2 ,0.001
Age presented in years. CADB- coronary artery disease burden; Ca- plasma
calcium, mmol/l; P- plasma phosphorus, mg/L; Mg- plasma magnesium, mEq/l;
HDL- high density lipoprotein cholesterol, mg/dl; LDL- low density lipoprotein
cholesterol, mg/dl; TG- triglycerides, mg/dl; Glucose- fasting plasma glucose,
mg/dl; BMI- body mass index (Kg/m
2); eGFR- estimated glomerular filtration
rate, ml/min/1.73 m
2; uric acid- plasma uric acid, mg/L; N- number; p –
probability (Mann- Whitney U test).
doi:10.1371/journal.pone.0004322.t003
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role in cell proliferation [22].
Magnesium seems to act as a cofactor for insulin receptor-
associated tyrosine kinase activity [22], one among a large number
of physiological actions of this element. Considerable controversy
exists concerning the role of magnesium in cardiovascular disease
[9]. Uric acid has been suggested to play a role in cardiorenal
disease, namely in arterial hypertension, but also in coronary
artery disease [11]. In the present investigation, plasma uric acid
was correlated to CADB in univariate but not in linear regression
analysis.
In the context of the present investigation, one may speculate
that higher plasma glucose, probably in the presence of elevated
plasma insulin, could be associated to a growth-stimulating effect
on atherosclerotic lesions, perhaps involving magnesium as a
cofactor for insulin-stimulated growth. This latter phenomenon, at
least in vascular smooth muscle cells, may depend on the
stimulation of intracellular pathways involving mitogen-activated
protein kinases [23] (for review please see ref. 22). Recent data
show that the use of an insulin sensitizer (pioglitazone) was
associated with a lower rate of progression of coronary
atherosclerosis than the use of an insulin secretagogue (glimepiride)
in patients with type 2 diabetes [24], data that may be interpreted
taking into consideration the line of reasoning presented above.
The data concerning the subgroup analysis (male/female) must
be viewed with great caution, since it is not clear that the clinical
background is similar for both subgroups of patients. The well-
known finding of higher HDL cholesterol in female patients [25]
was seen, but it is unclear if the remaining findings (females with
higher BMI, LDL cholesterol, and phosphorus, lower uric acid
and CADB) could represent a common pattern in patients with
coronary atherosclerosis.
Limitations of the present study include the relatively small
sample of patients. Angiography is a technique that detects major
coronary arterial lesions, leaving important segments of diseased
vessels unrecognized as such [26]. Patients were observed as
outpatients at a cardiology clinic, and so several types of selection
bias may be at play. The authors would also like to stress the
limitations of not including treatment factors in the analysis as well
as the variable time between biomarker and angiography
measurements in the study population. Patients were frequently
under the influence of drugs, both lipid-lowering and anti-diabetic.
Thus, particularly in what concerns the LDL data, these results
must be viewed with great caution. Several parameters were under
study, and so a cautionary note on the findings in the background
of tests on multiple parameters is warranted. Given these
limitations, the present findings should be, preferably, confirmed
by other studies.
In conclusion, among several systemic parameters studied,
plasma glucose was found to be correlated to coronary artery
atherosclerosis lesions.
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